On the other hand, EGFR T790M mutations were observed in NSCLC DTPs that were T790M-negative a priori (61, 87), indicating that DTPs provide a pool of cells from which various genetic modes of resistance can evolve (87) (Figure 2B). This evidence concerns the gene EGFR and non-small cell lung carcinoma.